The identification of the cAMP signaling pathway, PI3K/AKT signaling pathway, and VEGF signaling pathway have been verified by many studies to play an important role in the occurrence and development of breast cancer and are closely related to endocrine therapy resistance in the later period of breast cancer [34,35,36,37,38]. This evidence concerns the gene AKT1 and breast cancer.